From GlobeNewswire: 2025-06-05 11:15:00

Inspira Technologies is ramping up production of its FDA-cleared INSPIRA ART100 system in response to expected demand from a European governmental authority. The ART100 system is gaining traction in clinical settings for critical care and emergency preparedness programs. CEO Dagi Ben Noon states the move is to meet deployment needs efficiently. This follows the Company’s recent announcement of a global rollout strategy. Inspira believes the current momentum in scalable respiratory solutions may position them as a strategic public health supplier. The Company specializes in advanced respiratory support and real-time blood monitoring solutions, with a focus on developing next-generation platforms.



Read more at GlobeNewswire: Inspira Scales Up ART100 Production